Early relapse of atypical hemolytic uremic syndrome following ABO-incompatible living–related pediatric kidney re-transplant successfully treated with eculizumab

MLA

Jelena Stojanovic, et al. “Early Relapse of Atypical Hemolytic Uremic Syndrome Following ABO-Incompatible Living–related Pediatric Kidney Re-Transplant Successfully Treated with Eculizumab.” Pediatric Nephrology, vol. 36, July 2021, pp. 3271–75. EBSCOhost, https://doi.org/10.1007/s00467-021-05193-7.

APA

Jelena Stojanovic, Nizam Mamode, Aoife M. Waters, Nicos Kessaris, Stephen D. Marks, Neil J. Sebire, & Anna Adamusiak. (2021). Early relapse of atypical hemolytic uremic syndrome following ABO-incompatible living–related pediatric kidney re-transplant successfully treated with eculizumab. Pediatric Nephrology, 36, 3271–3275. https://doi.org/10.1007/s00467-021-05193-7

Chicago

Jelena Stojanovic, Nizam Mamode, Aoife M. Waters, Nicos Kessaris, Stephen D. Marks, Neil J. Sebire, and Anna Adamusiak. 2021. “Early Relapse of Atypical Hemolytic Uremic Syndrome Following ABO-Incompatible Living–related Pediatric Kidney Re-Transplant Successfully Treated with Eculizumab.” Pediatric Nephrology 36 (July): 3271–75. doi:10.1007/s00467-021-05193-7.